Skip to Content

What is Braftovi used to treat?

Answers (1)

Official Answer by Drugs.com 23 Aug 2018
Braftovi (encorafenib) from Array BioPharma, along with Mektovi (binimetinib), is part of an oral BRAF/MEK inhibitor combination therapy used for patients with unresectable or metastatic melanoma (skin cancer that has spread) with a BRAF V600E or V600K gene mutation, as detected by an FDA-approved test. Both Braftovi and Mektovi are kinase inhibitors. Roughly 50% of patients diagnosed with metastatic melanoma test positive for the BRAF mutation, and it is the most common genetic mutation in metastatic melanoma. Braftovi is not indicated for the treatment of patients with wild-type BRAF melanoma.
Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 7 Jan 2019 1 answerFAQ by Drugs.com

How do you use the ProAir Digihaler?

Updated 7 Jan 2019 1 answerFAQ by Drugs.com

How many biosimilars have been approved in the United States?

Updated 8 Jan 2019 1 answerFAQ by Drugs.com

What are the brands of sumatriptan?

Updated 5 Feb 2019 1 answerFAQ by Drugs.com

What is botulinum toxin used to treat?

Updated 14 Feb 2019 1 answerFAQ by Drugs.com